Panagora Asset Management Inc Bridge Bio Pharma, Inc. Transaction History
Panagora Asset Management Inc
- $21 Billion
- Q4 2024
A detailed history of Panagora Asset Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 508,807 shares of BBIO stock, worth $17.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
508,807
Previous 748,819
32.05%
Holding current value
$17.7 Million
Previous $19.1 Million
26.77%
% of portfolio
0.07%
Previous 0.09%
Shares
9 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$878 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$873 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$433 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$215 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.15B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...